Boceprevir
Drug Details
- Description
- Boceprevir is an oral protease inhibitor used in combination with other medications to treat chronic hepatitis C virus (HCV) infection, genotype 1. It inhibits the HCV nonstructural protein 3 (NS3) serine protease, essential for viral replication.
- Alternative Names
- Boceprevir.
- Key Genes
- Boceprevir is influenced by genetic variations in IL28B, affecting treatment response in hepatitis C patients. Variants in IL28B can help predict the likelihood of achieving a sustained virologic response.
- Drug Use
- Boceprevir is an antiviral medication used to treat chronic hepatitis C infection, specifically genotype 1, in combination with peginterferon alfa and ribavirin.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report